Zai Lab aims to raise $200M; Kronos Bio to seek ‘strategic’ options
Plus, news about Allogene, Telix, Cullgen, Pulmatrix, Gilead, Innocoll, Durect and Sensei:
Zai Lab’s $200M offering: The Shanghai-based drugmaker is
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
